Article Details
Retrieved on: 2022-05-23 22:32:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Biohaven's migraine drug research led to an FDA-approved product with strong commercial uptake, but its' other neuroscience efforts have yet to ...
Article found on: medcitynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here